Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Debra L. Fleenor is active.

Publication


Featured researches published by Debra L. Fleenor.


BMC Neuroscience | 2007

Pigment epithelium-derived factor protects retinal ganglion cells

Iok-Hou Pang; H. Zeng; Debra L. Fleenor; Abbot F. Clark

BackgroundRetinal ganglion cells (RGCs) are responsible for the transmission of visual signals to the brain. Progressive death of RGCs occurs in glaucoma and several other retinal diseases, which can lead to visual impairment and blindness. Pigment epithelium-derived factor (PEDF) is a potent antiangiogenic, neurotrophic and neuroprotective protein that can protect neurons from a variety of pathologic insults. We tested the effects of PEDF on the survival of cultured adult rat RGCs in the presence of glaucoma-like insults, including cytotoxicity induced by glutamate or withdrawal of trophic factors.ResultsCultured adult rat RGCs exposed to glutamate for 3 days showed signs of cytotoxicity and death. The toxic effect of glutamate was concentration-dependent (EC50 = 31 μM). In the presence of 100 μM glutamate, RGC number decreased to 55 ± 4% of control (mean ± SEM, n = 76; P < 0.001). The glutamate effect was completely eliminated by MK801, an NMDA receptor antagonist. Trophic factor withdrawal also caused a similar loss of RGCs (54 ± 4%, n = 60, P < 0.001). PEDF protected against both insults with EC50 values of 13.6 ng/mL (glutamate) and 3.4 ng/mL (trophic factor withdrawal), respectively. At 100 ng/mL, PEDF completely protected the cells from both insults. Inhibitors of the nuclear factor κB (NFκB) and extracellular signal-regulated kinases 1/2 (ERK1/2) significantly reduced the protective effects of PEDF.ConclusionWe demonstrated that PEDF potently and efficaciously protected adult rat RGCs from glutamate- and trophic factor withdrawal-mediated cytotoxicity, via the activation of the NFκB and ERK1/2 pathways. The neuroprotective effect of PEDF represents a novel approach for potential treatment of retinopathies, such as glaucoma.


Investigative Ophthalmology & Visual Science | 2010

Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells.

Jia Ma; Wenhan Yu; Yun Wang; Guiqun Cao; Suping Cai; Xiaoming Chen; Naihong Yan; Yuansheng Yuan; H. Zeng; Debra L. Fleenor; Xuyang Liu; Iok-Hou Pang

PURPOSE. To evaluate the potential neuroprotective effects of C-type natriuretic peptide (CNP) on rat retinal ganglion cells (RGCs). METHODS. Cultured adult rat retinal cells were treated with vehicle, CNP, or atrial natriuretic peptide (ANP), followed by cytotoxic insults (glutamate, TNFalpha, or withdrawal of trophic factor). RGC survival was analyzed by counting Thy-1-positive cells in each well. For in vivo evaluation, N-methyl-d-aspartate (NMDA) with or without CNP was injected intravitreally into rat eyes. At various time points after injection, retinal cross-sections were analyzed for thickness changes in the retinal layers, and retinal flat mounts were assessed by counting cresyl violet-labeled or TUNEL-positive cells. Expressions of natriuretic peptide receptor-B (NPRB) and apoptosis-related genes in retina, including Bcl-xL, BAX, and micro-calpain, were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). RESULTS. At 50 and 500 nM, CNP, but not ANP, significantly (P < 0.05) protected against glutamate-insult and trophic factor withdrawal-induced RGC death in vitro. Neither peptide significantly affected TNFalpha-induced cytotoxicity. Intravitreal injection of NMDA (20 nanomoles) significantly (P < 0.05) decreased the thickness of the inner plexiform layer (IPL), induced cell loss, increased the number of TUNEL-positive cells in the RGC layer, and upregulated the expression of Bcl-xL, BAX, and micro-calpain. All these effects were significantly (P < 0.05) alleviated by concomitant injection of CNP (4.5 nmol, 10 microg). The neuroprotective effects of CNP were maintained up to 14 days after CNP injection. CONCLUSIONS. CNP protects rat RGCs against the apoptotic damage induced by insults such as excitatory amino acid, both in vitro and in vivo.


Investigative Ophthalmology & Visual Science | 2006

TGFβ2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure

Debra L. Fleenor; Allan R. Shepard; Peggy E. Hellberg; Nasreen Jacobson; Iok-Hou Pang; Abbot F. Clark


Investigative Ophthalmology & Visual Science | 2007

Effects of TGF-β2, BMP-4, and Gremlin in the Trabecular Meshwork: Implications for Glaucoma

Robert J. Wordinger; Debra L. Fleenor; Peggy E. Hellberg; Iok-Hou Pang; Tara O. Tovar; Gulab Zode; J. Fuller; Abbot F. Clark


Investigative Ophthalmology & Visual Science | 2003

Expression of Matrix Metalloproteinases and Their Inhibitors in Human Trabecular Meshwork Cells

Iok-Hou Pang; Peggy E. Hellberg; Debra L. Fleenor; Nasreen Jacobson; Abbot F. Clark


Investigative Ophthalmology & Visual Science | 2003

Role of histidine in cataract formation in Atlantic salmon (Salmo salar L).

Debra L. Fleenor; Iok-Hou Pang; Abbot F. Clark


Investigative Ophthalmology & Visual Science | 2003

Aqueous outflow-enhancing effect of tert-butylhydroquinone: involvement of AP-1 activation and MMP-3 expression.

Iok-Hou Pang; Debra L. Fleenor; Peggy E. Hellberg; Karen Stropki; Mitchell D. McCartney; Abbot F. Clark


Archive | 2003

AGENTS WHICH REGULATE, INHIBIT, OR MODULATE THE ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A UNIQUE MEANS TO BOTH LOWER INTRAOCULAR PRESSURE AND TREAT GLAUCOMATOUS RETINOPATHIES/OPTIC NEUROPATHIES

Debra L. Fleenor; Allan R. Shepard; Nasreen Jacobson; Iok-Hou Pang; Abbot F. Clark


Archive | 2006

Control of intraocular pressure using alk5 modulation agents

Debra L. Fleenor; Iok-Hou Pang; Allan Shepard; Mark R. Hellberg; Abbot F. Clark; Peter G. Klimko


Archive | 2007

Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders

Debra L. Fleenor; Allan R. Shepard; Iok-Hou Pang

Collaboration


Dive into the Debra L. Fleenor's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Iok-Hou Pang

University of North Texas Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Iok-Hou Pang

University of North Texas Health Science Center

View shared research outputs
Top Co-Authors

Avatar

A. F. Clark

University of North Texas

View shared research outputs
Top Co-Authors

Avatar

Iok-Hou Pang

University of North Texas Health Science Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge